You have read all your free articles, to continue reading subscribe to read the rest of this content.
Sobi together with its Australian partner, A. Menarini Australia Pty Ltd have received marketing authorisation in Australia for Kineret (anakinra) for the treatment of systemic juvenile idiopathic arthritis (SJIA), which is a rare form of juvenile chronic arthritis. "We are pleased and encouragedAlready a subscriber Login You have read all…
The companies have signed a collaboration and distribution agreement that gives Thermo Fisher exclusive rights to commercialize, under combined brands, Devyser’s post-transplant portfolio of NGS products in North America and Europe. “Partnering with Thermo Fisher, the leading innovator in theAlready a subscriber Login You have read all your free articles,…
The Swedish/Danish biotech company 2A Pharma has closed its first financing round and has been granted an exclusive, worldwide license from Medigene for its adeno-associated virus like particles (AAVLPs) technology. 2A Pharma AB, based in Malmö, Sweden with research facilities in Aalborg, DenmarAlready a subscriber Login You have read all…
Finnish startup Finnadvance has secured a 1.2 million EUR seed financing round led by Finnish investor Athensmed. Several existing investors, such as deep tech VC Voima Ventures and early-stage VC Icebreaker, are participating in the funding round. In addition, the funding also includes a new invAlready a subscriber Login You…
